{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:38:38Z","timestamp":1790545118342,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.atherosclerosis.2018.01.029","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T04:00:26Z","timestamp":1517371226000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Prognostic value of suPAR and hs-CRP on cardiovascular disease"],"prefix":"10.1016","volume":"271","author":[{"given":"Marie Z\u00f6ga","family":"Diederichsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Z\u00f6ga","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Mickley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0252-6631","authenticated-orcid":false,"given":"Flemming Hald","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Lambrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Peter R\u00f8nnow","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent Lodberg","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-4826","authenticated-orcid":false,"given":"Axel","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Hjortdal","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.01.029_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","volume":"252","author":"Piepoli","year":"2016","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.01.029_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.115.016846","article-title":"Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 american College of cardiology\/american heart association cholesterol guidelines","volume":"132","author":"Yeboah","year":"2015","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2018.01.029_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies","volume":"108","author":"Naghavi","year":"2003","journal-title":"Part II. Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.01.029_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ypmed.2008.07.012","article-title":"Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool","volume":"47","author":"Cavanaugh-Hussey","year":"2008","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.01.029_bib5","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.ijcard.2012.07.018","article-title":"Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score","volume":"167","author":"Lyngb\u00e6k","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2018.01.029_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis","volume":"56","author":"Erbel","year":"2010","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2018.01.029_bib7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"Jama"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2018.01.029_bib8","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Goff","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2018.01.029_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq transatlantic Network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"9709","key":"10.1016\/j.atherosclerosis.2018.01.029_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Collaboration ERF","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.01.029_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population: suPAR: a novel risk marker for major disease and mortality","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J.\u00a0Intern. Med."},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2018.01.029_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.01.029_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1741826711409172","article-title":"Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study","volume":"19","author":"Diederichsen","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.01.029_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2796.2011.02486.x","article-title":"The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy","volume":"271","author":"Lambrechtsen","year":"2012","journal-title":"J.\u00a0Intern. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.01.029_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2014.08.035","article-title":"Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects","volume":"237","author":"S\u00f8rensen","year":"2014","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.01.029_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2008.07.072","article-title":"Coronary calcium predicts events better with absolute calcium scores than age-sex-race\/ethnicity percentiles: MESA (Multi-Ethnic study of atherosclerosis)","volume":"53","author":"Budoff","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.01.029_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat. Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.01.029_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.01.029_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","article-title":"Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease","volume":"45","author":"Persson","year":"2014","journal-title":"Stroke"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2018.01.029_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","article-title":"10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors","volume":"66","author":"McClelland","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.01.029_bib21","article-title":"Risk stratification for primary prevention of coronary artery disease: roles of C-Reactive protein and coronary artery calcium","volume":"17","author":"Qureshi","year":"2015","journal-title":"Curr Cardiol Rep [Internet]"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.01.029_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2005.02.088","article-title":"Disease events","volume":"46","author":"Arad","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2018.01.029_bib23","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.CIR.0000033819.29662.09","article-title":"Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals","volume":"106","author":"Park","year":"2002","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2018.01.029_bib24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2010.10.043","article-title":"Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality","volume":"57","author":"M\u00f6hlenkamp","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.01.029_bib25","article-title":"Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events","volume":"3","author":"Eapen","year":"2014","journal-title":"J.\u00a0Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.01.029_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2009.08.037","article-title":"Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis","volume":"209","author":"Jenny","year":"2010","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.01.029_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jcmg.2017.05.010","article-title":"CT-detected growth of coronary artery calcification in asymptomatic middle-aged subjects and association with 15 biomarkers","volume":"10","author":"Diederichsen","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.01.029_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.01.029_bib29","first-page":"53","article-title":"Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis","author":"Leg\u00e1ny","year":"2015","journal-title":"Clin Chem Lab Med CCLM [Internet]"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.01.029_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.carpath.2013.04.005","article-title":"Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques","volume":"22","author":"Asciutto","year":"2013","journal-title":"Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.01.029_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10554-012-0091-8","article-title":"Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy","volume":"29","author":"Bjerrum","year":"2013","journal-title":"Int J Cardiovasc Imaging"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018300303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018300303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T09:11:41Z","timestamp":1603703501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018300303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"alternative-id":["S0021915018300303"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.029","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of suPAR and hs-CRP on cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}